Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Phase II Study of Azacitidine in Myelofibrosis.

Trial Profile

Phase II Study of Azacitidine in Myelofibrosis.

Phase of Trial: Phase II

Latest Information Update: 21 Jan 2011

At a glance

  • Drugs Azacitidine (Primary)
  • Indications Myelofibrosis
  • Focus Therapeutic Use
  • Most Recent Events

    • 21 Jan 2011 Status changed from completed to discontinued as reported by ClinicalTrials.gov.
    • 09 Jun 2009 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
    • 17 Dec 2007 The expected completion date for this trial is now 1 Dec 2008.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top